Trivascular Snags $30M
Santa Rosa-based TriVascular, a developer of stent graft treatments for abdominal and thoracic aortic disease, said this week that it has raised $30M in a Series B funding round. The firm said the funding came from New Enterprise Associates, Delphi Ventures, MPM Capital, and Kearny Venture Partners, all existing investors in the firm. The company said the new funding round will go towards its operations and infrastructure.
posted on Friday, November 20, 2009 (Link to more information)
Related companies:
Trivascular
Related stories:
> Trivascular Raises $60M
> App.net Snags $2.5M For Social App Tools
> Satellogic Snags $27M
> ScaleFlux Snags $25M
> Reply.com Snags $15M In Debt Funding
silicontap.com Home